AB-BIOTICS is a Spanish company founded in Barcelona in 2004, leading Biotechnology and whose activity is diversified into two business areas based on the research, development, protection and distribution of biotech own unique solutions, with a mission to improve the health and wellbeing of people.
AB-BIOTICS has an innovative philosophy and has a know-how that allows itself to develop cutting-edge products that provide high added value to market. The AB-BIOTICS projects offer the pharmaceutical and food products greater efficiency and help to improve the health of people while helping reduce health care costs.
AB-BIOTICS is organized into two business areas:
- NEUROFARMAGEN (AB-GENOTYPING): focuses on the development of genetic analysis to develop pharmacogenetic studies (the way in which patients will respond to different treatments and drugs, based on their genetic inheritance) which provide more information to doctors about the most effective treatments and appropriate dose for each patient (personalized medicine).
- AB-BIOTICS FUNCTIONAL INGREDIENTS: probiotics and other nutraceuticals are developed for the pharmaceutical industry and food industries. These functional ingredients are useful for the prevention and treatment of a wide range of illnesses, from cardiovascular to infantile colic, among others.
AB-BIOTICS has a multidisciplinary team led by counselors Miquel Angel Bonachera and Sergi Audivert. The organization combines the talents of young, dynamic and highly qualified professionals with extensive international experience and success in business and biotechnology.